Mio-Sed
Mio-Sed Brand names, Mio-Sed Analogs
- Alinam
- Banabil-sintyal
- Banabin
- Banabin-Sintyal
- Banabin-syntyal
- Bisina
- Chlomedinon
- Chlormethazanone
- Chlormethazone
- Chlormezanon
- Chlormezanone [BAN:INN:JAN]
- Chlormezanonum [INN-Latin]
- Clorilax
- Clormetazanone
- Clormetazon
- Clormezanona [INN-Spanish]
- Clormezanone [DCIT]
- Dichloromethazanone
- Dichloromezanone
- Fenarol
- Lobak
- Mio-Sed
- Miorilax
- Muskel
- Muskel-Trancopal
- Myolespen
- Phenarol
- Rexan
- Rilansyl
- Rilaquil
- Rilasol
- Rilassol
- Rilax
- Rillasol
- Supotran
- Suprotan
- Tanafol
- Trancopal
- Trancote
- Tranrilax
- Transanate
- dl-Chlormezanone
Mio-Sed Brand Names Mixture
- No information avaliable
Mio-Sed Chemical_Formula
C11H12ClNO3S
Mio-Sed RX_link
No information avaliable
Mio-Sed fda sheet
Mio-Sed msds (material safety sheet)
Mio-Sed Synthesis Reference
No information avaliable
Mio-Sed Molecular Weight
273.737 g/mol
Mio-Sed Melting Point
116.2 oC
Mio-Sed H2O Solubility
2500 mg/L (hardly soluble)
Mio-Sed State
Solid
Mio-Sed LogP
1.208
Mio-Sed Dosage Forms
No information avaliable
Mio-Sed Indication
Used in the management of anxiety and in the treatment of muscle spasm.
Mio-Sed Pharmacology
Chlormezanone is a non-benzodiazepine muscle relaxant. It was discontinued worldwide in 1996 by its manufacturer due to confirmed serious and rare cutaneous reactions (toxic epidermal necrolysis).
Mio-Sed Absorption
No information avaliable
Mio-Sed side effects and Toxicity
Symptoms of overdose include drowsiness, weakness, nausea, dizziness, abdominal pain, cerebral oedema and renal tubular necrosis, hyperglycaemia and hypoglycaemia, liver damage, encephalopathy, coma and death.
Mio-Sed Patient Information
No information avaliable
Mio-Sed Organisms Affected
Humans and other mammals
